Viking Therapeutics, Inc. SEC filings VKTX

Viking Therapeutics, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 22, 2014. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

Viking Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
8-K Current report
Material agreement, New debt
Sep 28, 2026 Sep 23, 2026
424B5 Prospectus supplement Sep 25, 2026 —
424B5 Prospectus supplement Sep 25, 2026 —
FWP Free writing prospectus Sep 24, 2026 —
305B2 Application for designation of a new trustee Sep 24, 2026 —
424B5 Prospectus supplement Sep 23, 2026 —
424B5 Prospectus supplement Sep 23, 2026 —
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
S-3ASR Automatic shelf registration Jul 30, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Shareholder vote results
May 26, 2026 May 19, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
ARS Annual report to shareholders Apr 1, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 1, 2026 —
DEF 14A Proxy statement Apr 1, 2026 May 19, 2026
10-K Annual report Feb 11, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
10-Q Quarterly report Oct 23, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 22, 2025 Oct 22, 2025
8-K Current report
Regulation FD disclosure
Aug 19, 2025 Aug 19, 2025
10-Q Quarterly report Jul 23, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 23, 2025 Jul 23, 2025
8-K Current report
Shareholder vote results
May 27, 2025 May 20, 2025
10-Q Quarterly report Apr 24, 2025 Mar 31, 2025
DEFA14A Additional proxy material Apr 23, 2025 —
DEFR14A Filing Apr 23, 2025 —
8-K Current report
Results of operations
Apr 23, 2025 Apr 23, 2025
8-K Current report
Auditor change, Other events
Apr 23, 2025 Apr 18, 2025
UPLOAD Letter from the SEC Apr 21, 2025 —
CORRESP Letter to the SEC Apr 8, 2025 —
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 20, 2025
UPLOAD Letter from the SEC Mar 31, 2025 —
8-K Current report
Material agreement, New debt, Other events
Mar 11, 2025 Mar 10, 2025
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 5, 2025 Feb 5, 2025
8-K Current report
Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
10-Q Quarterly report Oct 23, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 23, 2024 Oct 23, 2024
10-Q Quarterly report Jul 24, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 24, 2024 Jul 24, 2024
8-K Current report
Regulation FD disclosure
Jun 4, 2024 Jun 4, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2024 May 21, 2024
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 22, 2024 —
S-8 Employee stock plan registration May 22, 2024 —
10-Q Quarterly report Apr 25, 2024 Mar 31, 2024
8-K Current report
Results of operations
Apr 24, 2024 Apr 24, 2024
ARS Annual report to shareholders Apr 5, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 5, 2024 —
DEF 14A Proxy statement Apr 5, 2024 May 21, 2024
8-K Current report
Regulation FD disclosure
Mar 26, 2024 Mar 26, 2024
8-K Current report
Other events
Mar 4, 2024 Mar 4, 2024
424B5 Prospectus supplement Mar 1, 2024 —
8-K Current report
Material agreement, Other events
Mar 1, 2024 Feb 28, 2024
424B5 Prospectus supplement Feb 27, 2024 —
8-K Current report
Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
S-8 Employee stock plan registration Feb 7, 2024 —
10-K Annual report Feb 7, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 7, 2024 Feb 7, 2024
10-Q Quarterly report Oct 25, 2023 Sep 30, 2023
8-K Current report
Results of operations
Oct 25, 2023 Oct 25, 2023
S-3ASR Automatic shelf registration Jul 26, 2023 —
10-Q Quarterly report Jul 26, 2023 Jun 30, 2023
8-K Current report
Results of operations
Jul 26, 2023 Jul 26, 2023
8-K Current report
Shareholder vote results
Jun 14, 2023 Jun 13, 2023
8-K Current report
Bylaw or fiscal year change
May 11, 2023 May 9, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
10-Q Quarterly report Apr 26, 2023 Mar 31, 2023
8-K Current report
Results of operations
Apr 26, 2023 Apr 26, 2023
PRE 14A Preliminary proxy statement Apr 17, 2023 —
8-K Current report
Other events
Apr 3, 2023 Apr 3, 2023
8-K Current report
Material agreement, Other events
Mar 31, 2023 Mar 29, 2023
424B5 Prospectus supplement Mar 31, 2023 —
424B5 Prospectus supplement Mar 29, 2023 —
8-K Current report
Regulation FD disclosure
Mar 28, 2023 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Mar 28, 2023 Mar 28, 2023
S-8 Employee stock plan registration Feb 10, 2023 —
10-K Annual report Feb 10, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 8, 2023 Feb 8, 2023
10-Q Quarterly report Oct 26, 2022 Sep 30, 2022
8-K Current report
Results of operations
Oct 26, 2022 Oct 26, 2022
10-Q Quarterly report Jul 27, 2022 Jun 30, 2022
8-K Current report
Results of operations
Jul 27, 2022 Jul 27, 2022
8-K Current report
Shareholder vote results
May 26, 2022 May 24, 2022
10-Q Quarterly report Apr 27, 2022 Mar 31, 2022
8-K Current report
Results of operations
Apr 27, 2022 Apr 27, 2022
DEFA14A Additional proxy material Apr 7, 2022 —
DEF 14A Proxy statement Apr 7, 2022 May 24, 2022
S-8 Employee stock plan registration Feb 9, 2022 —
10-K Annual report Feb 9, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 9, 2022 Feb 9, 2022
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
EFFECT Filing Aug 11, 2021 —
424B5 Prospectus supplement Aug 11, 2021 —
CORRESP Letter to the SEC Aug 5, 2021 —
UPLOAD Letter from the SEC Aug 2, 2021 —
8-K Current report
Material agreement, Agreement ended
Jul 28, 2021 Jul 28, 2021
S-3 Shelf registration Jul 28, 2021 —
10-Q Quarterly report Jul 28, 2021 Jun 30, 2021
8-K Current report
Results of operations
Jul 28, 2021 Jul 28, 2021
8-K Current report
Shareholder vote results
May 21, 2021 May 20, 2021
10-Q Quarterly report Apr 28, 2021 Mar 31, 2021
8-K Current report
Results of operations
Apr 28, 2021 Apr 28, 2021
DEFA14A Additional proxy material Apr 8, 2021 —
DEF 14A Proxy statement Apr 8, 2021 May 20, 2021
25-NSE Delisting notice Apr 8, 2021 —
S-8 Employee stock plan registration Feb 17, 2021 —
10-K Annual report Feb 17, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 17, 2021 Feb 17, 2021
8-K Current report
Officer or director change
Jan 6, 2021 Jan 4, 2021
10-Q Quarterly report Oct 28, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 28, 2020 Oct 28, 2020
10-Q Quarterly report Jul 29, 2020 Jun 30, 2020
8-K Current report
Results of operations
Jul 29, 2020 Jul 29, 2020
8-K Current report
Shareholder vote results
May 21, 2020 May 21, 2020
DEFA14A Additional proxy material May 20, 2020 —
10-Q Quarterly report Apr 30, 2020 Mar 31, 2020
8-K Current report
Results of operations
Apr 30, 2020 Apr 30, 2020
DEFA14A Additional proxy material Apr 6, 2020 —
DEF 14A Proxy statement Apr 6, 2020 May 21, 2020
8-K Current report
Regulation FD disclosure
Mar 17, 2020 Mar 17, 2020
S-8 Employee stock plan registration Feb 26, 2020 —
10-K Annual report Feb 26, 2020 Dec 31, 2019
CT ORDER Filing Feb 19, 2020 —
10-Q Quarterly report Nov 5, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 5, 2019 Nov 5, 2019
8-K Current report
Material agreement
Aug 2, 2019 Aug 1, 2019
424B5 Prospectus supplement Aug 2, 2019 —
10-Q Quarterly report Aug 1, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 1, 2019 Aug 1, 2019
8-K Current report
Officer or director change
Jul 2, 2019 Jul 1, 2019
8-K Current report
Shareholder vote results
May 23, 2019 May 23, 2019
10-Q Quarterly report May 2, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
DEFA14A Additional proxy material Apr 5, 2019 —
DEF 14A Proxy statement Apr 5, 2019 May 23, 2019
S-8 Employee stock plan registration Mar 13, 2019 —
10-K Annual report Mar 13, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 13, 2019 Mar 13, 2019
10-Q Quarterly report Nov 7, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 7, 2018 Nov 7, 2018
424B5 Prospectus supplement Sep 21, 2018 —
8-K Current report
Material agreement, Other events
Sep 21, 2018 Sep 20, 2018
424B5 Prospectus supplement Sep 19, 2018 —
8-K Current report
Regulation FD disclosure
Sep 18, 2018 Sep 18, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
EFFECT Filing Jul 19, 2018 —
CORRESP Letter to the SEC Jul 17, 2018 —
UPLOAD Letter from the SEC Jul 17, 2018 —
S-3 Shelf registration Jul 11, 2018 —
8-K Current report
Other events
Jun 12, 2018 Jun 12, 2018
424B5 Prospectus supplement Jun 7, 2018 —
8-K Current report
Material agreement, Other events
Jun 7, 2018 Jun 7, 2018
S-3MEF S-3 mef Jun 7, 2018 —
424B5 Prospectus supplement Jun 6, 2018 —
8-K Current report
Material agreement, New debt, Shareholder vote results
May 31, 2018 May 24, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
DEFA14A Additional proxy material Apr 6, 2018 —
DEF 14A Proxy statement Apr 6, 2018 May 24, 2018
S-8 Employee stock plan registration Mar 7, 2018 —
10-K Annual report Mar 7, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 7, 2018 Mar 7, 2018
8-K Current report
Other events
Feb 6, 2018 Feb 6, 2018
424B5 Prospectus supplement Feb 5, 2018 —
8-K Current report
Material agreement, Other events
Feb 2, 2018 Feb 2, 2018
424B5 Prospectus supplement Feb 1, 2018 —
8-K Current report
Officer or director change
Jan 23, 2018 Jan 19, 2018
EFFECT Filing Jan 16, 2018 —
424B3 Prospectus Jan 16, 2018 —
CORRESP Letter to the SEC Jan 11, 2018 —
S-1/A Amended registration statement Jan 9, 2018 —
CORRESP Letter to the SEC Jan 3, 2018 —
CORRESP Letter to the SEC Dec 29, 2017 —
UPLOAD Letter from the SEC Dec 29, 2017 —
S-1 Registration statement Dec 20, 2017 —
8-K Current report
Other events
Dec 11, 2017 Dec 11, 2017
424B5 Prospectus supplement Dec 7, 2017 —
8-K Current report
Material agreement, Other events
Dec 7, 2017 Dec 6, 2017
424B5 Prospectus supplement Dec 5, 2017 —
8-K Current report
Regulation FD disclosure
Nov 28, 2017 Nov 28, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VKTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1607678

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.